Page last updated: 2024-08-17

cholestanol and Cardiovascular Diseases

cholestanol has been researched along with Cardiovascular Diseases in 9 studies

Research

Studies (9)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (11.11)29.6817
2010's6 (66.67)24.3611
2020's2 (22.22)2.80

Authors

AuthorsStudies
Duarte, K; Fauler, G; Fellström, B; Girerd, N; Jardine, AG; März, W; Massy, ZA; Rossignol, P; Sadiku, S; Scharnagl, H; Schmieder, RE; Silbernagel, G; Zannad, F1
Endress, G; Geller, AS; Schaefer, EJ1
Bernalier-Donadille, A; Blond, E; Blot, A; Bodin, JP; Caille, A; Cheillan, D; Combe, E; Cotte, E; Domingues-Faria, C; Drai, J; Gaborit, P; Gésan-Guiziou, G; Joffre, F; Joumard-Cubizolles, L; Lambert-Porcheron, S; Laville, M; Le Barz, M; Lecomte, M; Malpuech-Brugère, C; Meiller, L; Michalski, MC; Morel-Laporte, F; Morio, B; Moulin, P; Ouchchane, L; Raynal, K; Sauvinet, V; Sothier, M; Vidal, H; Vors, C; Wauquier, A1
Baumgartner, I; Drechsler, C; Fauler, G; Genser, B; Grammer, TB; Krane, V; März, W; Ritz, E; Scharnagl, H; Silbernagel, G; Wanner, C1
Conceição, LL; Peluzio, MCG; Reis, SA; Rosa, DD; Siqueira, NP1
Gylling, H; Hallikainen, M; Miettinen, TA; Raitakari, OT; Viikari, J1
Boehm, BO; Fauler, G; Hoffmann, MM; Lütjohann, D; März, W; Silbernagel, G; Winkelmann, BR1
Ishibashi, S; Kotani, K; Miyamoto, M; Nagasaka, S; Okada, K; Osuga, J; Yagyu, H1
Amiot-Carlin, MJ; Defoort, C; Lairon, D; Nicolay, A; Portugal, H; Vergnes, MF; Wolff, E1

Reviews

2 review(s) available for cholestanol and Cardiovascular Diseases

ArticleYear
The biochemical and genetic diagnosis of lipid disorders.
    Current opinion in lipidology, 2019, Volume: 30, Issue:2

    Topics: Apolipoproteins; Biomarkers; Cardiovascular Diseases; Cholestanol; Cholesterol; Cholesterol, LDL; Fasting; Gene Expression; Genetic Predisposition to Disease; High-Throughput Nucleotide Sequencing; Humans; Lipid Metabolism Disorders; Lipoprotein(a); Mutation; Pancreatitis; Receptors, Lipoprotein; Sitosterols; Triglycerides

2019
Mechanisms responsible for the hypocholesterolaemic effect of regular consumption of probiotics.
    Nutrition research reviews, 2017, Volume: 30, Issue:1

    Topics: Animals; Anticholesteremic Agents; Bacteria; Bile Acids and Salts; Cardiovascular Diseases; Cell Membrane; Chemical Precipitation; Cholestanol; Cholesterol; Dyslipidemias; Humans; Intestinal Absorption; Intestinal Mucosa; Lipid Metabolism; Probiotics

2017

Trials

5 trial(s) available for cholestanol and Cardiovascular Diseases

ArticleYear
High cholesterol absorption is associated with increased cardiovascular risk in haemodialysis patients: insights from the AURORA study.
    European journal of preventive cardiology, 2022, 10-18, Volume: 29, Issue:13

    Topics: Atorvastatin; Cardiovascular Diseases; Cholestanol; Heart Disease Risk Factors; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Hyperlipidemias; Renal Dialysis; Risk Factors; Rosuvastatin Calcium; Sterols

2022
Milk polar lipids reduce lipid cardiovascular risk factors in overweight postmenopausal women: towards a gut sphingomyelin-cholesterol interplay.
    Gut, 2020, Volume: 69, Issue:3

    Topics: Animals; Apolipoprotein A-I; Apolipoprotein B-100; Cardiovascular Diseases; Cholestanol; Cholesterol; Cholesterol, HDL; Cross-Over Studies; Dietary Supplements; Double-Blind Method; Emulsifying Agents; Feces; Female; Gastrointestinal Microbiome; Humans; Ileostomy; Intestinal Absorption; Lipid Metabolism; Lipids; Middle Aged; Milk; Overweight; Postmenopause; Risk Factors; Sphingomyelins

2020
Intestinal cholesterol absorption, treatment with atorvastatin, and cardiovascular risk in hemodialysis patients.
    Journal of the American College of Cardiology, 2015, Jun-02, Volume: 65, Issue:21

    Topics: Aged; Atorvastatin; Cardiovascular Diseases; Cholestanol; Cholesterol; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Intestinal Absorption; Kidney Failure, Chronic; Male; Middle Aged; Pyrroles; Renal Dialysis

2015
Lipid-lowering effects of ezetimibe for hypercholesterolemic patients with and without type 2 diabetes mellitus.
    Endocrine journal, 2010, Volume: 57, Issue:10

    Topics: Aged; Azetidines; Biomarkers; Body Mass Index; C-Reactive Protein; Cardiovascular Diseases; Cholestanol; Cholesterol; Cholesterol, LDL; Diabetes Mellitus, Type 2; Ezetimibe; Female; Humans; Hypercholesterolemia; Hypolipidemic Agents; Lipids; Male; Middle Aged; Phytosterols; Sitosterols

2010
Cholesterol-absorber status modifies the LDL cholesterol-lowering effect of a Mediterranean-type diet in adults with moderate cardiovascular risk factors.
    The Journal of nutrition, 2011, Volume: 141, Issue:10

    Topics: Adult; Aged; Biomarkers; Cardiovascular Diseases; Cholestanol; Cholesterol; Cholesterol, Dietary; Cholesterol, LDL; Cohort Studies; Diet, Mediterranean; Female; France; Humans; Hypercholesterolemia; Intestinal Absorption; Male; Middle Aged; Risk Factors; Severity of Illness Index; Young Adult

2011

Other Studies

2 other study(ies) available for cholestanol and Cardiovascular Diseases

ArticleYear
Twenty-one year tracking of serum non-cholesterol sterols. The Cardiovascular Risk in Young Finns study.
    Nutrition, metabolism, and cardiovascular diseases : NMCD, 2009, Volume: 19, Issue:8

    Topics: Adolescent; Adult; Age Factors; Biomarkers; Body Mass Index; Cardiovascular Diseases; Child; Child, Preschool; Cholestanol; Cholesterol; Chromatography, Gas; Chromatography, Liquid; Desmosterol; Female; Finland; Follow-Up Studies; Humans; Intestinal Absorption; Male; Phytosterols; Population Surveillance; Registries; Risk Factors; Sitosterols; Time Factors

2009
The associations of cholesterol metabolism and plasma plant sterols with all-cause and cardiovascular mortality.
    Journal of lipid research, 2010, Volume: 51, Issue:8

    Topics: Absorption; Cardiovascular Diseases; Cholestanol; Cholesterol; Humans; Male; Middle Aged; Phytosterols; Prognosis; Risk; Sitosterols

2010